Clinical Trial Update: Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether the CPD gene influences body weight and fat mass reduction with perindopril in obese subjects was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• perindopril (perindopril)

Snippet

Sponsor: Gene PreDiT | Conditions: Obesity | Phase 2 | Status: TERMINATED